Table of Content

1 INTRODUCTION (Page No. - 22)
    1.1 STUDY OBJECTIVES
    1.2 MARKET DEFINITION AND SCOPE
           1.2.1 INCLUSIONS AND EXCLUSIONS
           1.2.2 MARKETS COVERED
                    FIGURE 1 MEDICAL DEVICE REPROCESSING MARKET SEGMENTATION
           1.2.3 YEARS CONSIDERED
    1.3 CURRENCY CONSIDERED
          TABLE 1 USD EXCHANGE RATES CONSIDERED, 2018-2021
    1.4 STAKEHOLDERS
    1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 26)
    2.1 RESEARCH APPROACH
    2.2 RESEARCH METHODOLOGY DESIGN
          FIGURE 2 MEDICAL DEVICE REPROCESSING MARKET: RESEARCH DESIGN
           2.2.1 SECONDARY DATA
                    2.2.1.1 Key data from secondary sources
           2.2.2 PRIMARY DATA
                    FIGURE 3 PRIMARY SOURCES
                    2.2.2.1 Key data from primary sources
                    2.2.2.2 Insights from primary experts
                                FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
                                FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.3 MARKET SIZE ESTIMATION
          FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
          FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION
          FIGURE 8 TOP-DOWN APPROACH
          FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
          FIGURE 10 CAGR PROJECTIONS
    2.4 DATA TRIANGULATION
          FIGURE 11 DATA TRIANGULATION METHODOLOGY
    2.5 MARKET SHARE ESTIMATION
    2.6 RESEARCH ASSUMPTIONS
    2.7 LIMITATIONS
           2.7.1 METHODOLOGY-RELATED LIMITATIONS
           2.7.2 SCOPE-RELATED LIMITATIONS
    2.8 RISK ASSESSMENT
          TABLE 2 RISK ASSESSMENT: MEDICAL DEVICE REPROCESSING MARKET

3 EXECUTIVE SUMMARY (Page No. - 39)
    FIGURE 12 MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    FIGURE 13 MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2022 VS. 2027 (USD MILLION)
    FIGURE 14 MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    FIGURE 15 GEOGRAPHICAL SNAPSHOT OF MEDICAL DEVICE REPROCESSING MARKET

4 PREMIUM INSIGHTS (Page No. - 43)
    4.1 BRIEF OVERVIEW OF MEDICAL DEVICE REPROCESSING MARKET
          FIGURE 16 INCREASING NEED TO MINIMIZE MEDICAL WASTE AND REDUCE HEALTHCARE COSTS TO DRIVE MARKET
    4.2 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE AND COUNTRY (2021)
          FIGURE 17 AUSTRALIA TO DOMINATE ASIA PACIFIC MEDICAL DEVICE REPROCESSING MARKET DURING FORECAST PERIOD
    4.3 MEDICAL DEVICE REPROCESSING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
          FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
    4.4 MEDICAL DEVICE REPROCESSING MARKET, BY REGION (2020–2027)
          FIGURE 19 NORTH AMERICA TO DOMINATE MARKET DURING FORECAST PERIOD
    4.5 MEDICAL DEVICE REPROCESSING MARKET: DEVELOPED VS. DEVELOPING MARKETS
          FIGURE 20 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 47)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
          FIGURE 21 MEDICAL DEVICE REPROCESSING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increasing level of supply chain cost savings in healthcare facilities
                    5.2.1.2 Growing adoption of strategies for sustainability and environmental safety
                                TABLE 3 EXAMPLES OF MARKET PLAYERS PROVIDING SUSTAINABILITY THROUGH REPROCESSING
                    5.2.1.3 Rising geriatric population
                                FIGURE 22 GLOBAL GERIATRIC POPULATION (65 YEARS & ABOVE), BY REGION
                                TABLE 4 IMPACT ANALYSIS: MARKET DRIVERS
           5.2.2 RESTRAINTS
                    5.2.2.1 Increasing risk of hospital-acquired infections among patients
                    5.2.2.2 Increasing number of medical device surface alterations due to reprocessing
                                TABLE 5 IMPACT ANALYSIS: RESTRAINTS
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Regulatory changes favoring adoption of medical device reprocessing
                    5.2.3.2 Growing opportunities and favorable regulations in developing countries
                                TABLE 6 IMPACT ANALYSIS: OPPORTUNITIES
           5.2.4 CHALLENGES
                    5.2.4.1 Stringent regulatory procedures for reprocessed medical devices
                                TABLE 7 IMPACT ANALYSIS: CHALLENGES
    5.3 KEY CONFERENCES AND EVENTS
          TABLE 8 MEDICAL DEVICE REPROCESSING MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
    5.4 INDUSTRY TRENDS
           5.4.1 EXPANDING SERVICE PORTFOLIO AND MARKET REACH THROUGH ACQUISITIONS
                    TABLE 9 MAJOR ACQUISITIONS IN MEDICAL DEVICE REPROCESSING MARKET
           5.4.2 SPECIALTY REPROCESSING
    5.5 PORTER’S FIVE FORCES ANALYSIS
          TABLE 10 PORTER’S FIVE FORCES ANALYSIS
           5.5.1 THREAT FROM NEW ENTRANTS
           5.5.2 THREAT FROM SUBSTITUTES
           5.5.3 BARGAINING POWER OF SUPPLIERS
           5.5.4 BARGAINING POWER OF BUYERS
           5.5.5 INTENSITY OF COMPETITIVE RIVALRY
    5.6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
          TABLE 11 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.7 REGULATORY ANALYSIS
           5.7.1 NORTH AMERICA
                    5.7.1.1 US
                                FIGURE 23 PREMARKET NOTIFICATION: 510 (K) APPROVAL FOR REPROCESSED MEDICAL DEVICES
                    5.7.1.2 Canada
           5.7.2 EUROPE
                    TABLE 12 EU COUNTRIES AND THEIR TERRITORY LAWS THAT AUTHORIZE SINGLE-USE DEVICE REPROCESSING
           5.7.3 ASIA PACIFIC
                    5.7.3.1 Japan
                    5.7.3.2 Australia
                    5.7.3.3 Rest of Asia Pacific
                                TABLE 13 INTERNATIONAL STANDARDS FOR MEDICAL DEVICE REPROCESSING
    5.8 TECHNOLOGY ANALYSIS
          TABLE 14 TECHNOLOGY AND INNOVATION IN MEDICAL DEVICE REPROCESSING MARKET
    5.9 SUPPLY CHAIN ANALYSIS
          FIGURE 24 SUPPLY CHAIN: MEDICAL DEVICE REPROCESSING MARKET
    5.10 ECOSYSTEM ANALYSIS
           FIGURE 25 MEDICAL DEVICE REPROCESSING MARKET: ECOSYSTEM ANALYSIS
    5.11 MEDICAL DEVICE REPROCESSING MARKET: PATENT ANALYSIS
           5.11.1 PATENT PUBLICATION TRENDS FOR MEDICAL DEVICE REPROCESSING
                     FIGURE 26 PATENT PUBLICATION TRENDS (2011–JULY 2022)
           5.11.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
                     FIGURE 27 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR MEDICAL DEVICE REPROCESSING (JANUARY 2011–JULY 2022)
                     FIGURE 28 TOP APPLICANT JURISDICTIONS FOR MEDICAL DEVICE REPROCESSING PATENTS (JANUARY 2011–JULY 2022)
                     TABLE 15 LIST OF PATENTS/PATENT APPLICATIONS IN MEDICAL DEVICE REPROCESSING MARKET, 2021–2022
    5.12 IMPACT OF COVID-19 ON MEDICAL DEVICE REPROCESSING MARKET

6 MEDICAL DEVICE REPROCESSING MARKET, BY TYPE (Page No. - 69)
    6.1 INTRODUCTION
          TABLE 16 MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
    6.2 REPROCESSING SUPPORT AND SERVICES
           6.2.1 REDUCING IN-HOUSE REPROCESSING COSTS AND INCREASING REGULATORY MANDATES TO DRIVE MARKET
                    TABLE 17 REPROCESSING SUPPORT AND SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.3 REPROCESSED MEDICAL DEVICES
           6.3.1 INCREASING ADOPTION OF REPROCESSED DEVICES AT LOWER COSTS TO DRIVE MARKET
                    TABLE 18 REPROCESSED MEDICAL DEVICES OFFERED BY KEY MARKET PLAYERS
                    TABLE 19 REPROCESSED MEDICAL DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

7 MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE (Page No. - 75)
    7.1 INTRODUCTION
          TABLE 20 MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
    7.2 CRITICAL DEVICES
           7.2.1 HIGH COST OF BUYING NEW DEVICES TO DRIVE MARKET
                    TABLE 21 REPROCESSED CRITICAL MEDICAL DEVICE CATEGORY
                    TABLE 22 CRITICAL DEVICES REPROCESSING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    7.3 SEMI-CRITICAL DEVICES
           7.3.1 INCREASED CASES OF HOSPITAL-ACQUIRED INFECTIONS TO DRIVE MARKET
                    TABLE 23 SEMI-CRITICAL DEVICE REPROCESSING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    7.4 NON-CRITICAL DEVICES
           7.4.1 INCREASING MEDICAL PROCEDURES AND SURGERIES TO DRIVE MARKET
                    TABLE 24 NON-CRITICAL DEVICE REPROCESSING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

8 MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION (Page No. - 81)
    8.1 INTRODUCTION
          TABLE 25 MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    8.2 CARDIOLOGY
           8.2.1 RISING CORONARY ARTERY DISEASE CASES TO PROPEL MARKET
                    TABLE 26 MEDICAL DEVICE REPROCESSING MARKET FOR CARDIOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
    8.3 GASTROENTEROLOGY
           8.3.1 INCREASING USE OF ENDOSCOPES FOR DISEASE DIAGNOSIS TO DRIVE MARKET
                    TABLE 27 MEDICAL DEVICE REPROCESSING MARKET FOR GASTROENTEROLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
    8.4 ARTHROSCOPY AND ORTHOPEDIC SURGERY
           8.4.1 REGULATORY INITIATIVES AND COST REDUCTION TO DRIVE MARKET
                    TABLE 28 APPROVED ORTHOPEDIC/ARTHROSCOPIC DEVICES FOR REPROCESSING
                    TABLE 29 MEDICAL DEVICE REPROCESSING MARKET FOR ARTHROSCOPY AND ORTHOPEDIC SURGERY, BY COUNTRY, 2020–2027 (USD MILLION)
    8.5 GYNECOLOGY
           8.5.1 INCREASING GYNECOLOGY PROCEDURES TO DRIVE MARKET
                    TABLE 30 MEDICAL DEVICE REPROCESSING MARKET FOR GYNECOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
    8.6 GENERAL SURGERY
           8.6.1 LOW-COST GENERAL SURGERY DEVICES TO IMPACT MARKET
                    TABLE 31 MEDICAL DEVICE REPROCESSING MARKET FOR GENERAL SURGERIES, BY COUNTRY, 2020–2027 (USD MILLION)
    8.7 OTHER APPLICATIONS
          TABLE 32 MEDICAL DEVICE REPROCESSING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)

9 MEDICAL DEVICE REPROCESSING MARKET, BY REGION (Page No. - 90)
    9.1 INTRODUCTION
          FIGURE 29 MEDICAL DEVICE REPROCESSING MARKET: GEOGRAPHIC SNAPSHOT (2021)
          TABLE 33 MEDICAL DEVICE REPROCESSING MARKET, BY REGION, 2020–2027 (USD MILLION)
    9.2 NORTH AMERICA
          FIGURE 30 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET SNAPSHOT
          TABLE 34 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 35 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 36 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
          TABLE 37 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           9.2.1 US
                    9.2.1.1 Presence of major players and healthcare cost reduction strategies to drive market
                                FIGURE 31 US: TOTAL NUMBER OF HOSPITALS
                                TABLE 38 US: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 39 US: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
                                TABLE 40 US: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           9.2.2 CANADA
                    9.2.2.1 Growing geriatric population and increasing chronic diseases to drive market
                                TABLE 41 CANADA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 42 CANADA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
                                TABLE 43 CANADA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    9.3 EUROPE
          TABLE 44 EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 45 EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 46 EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
          TABLE 47 EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           9.3.1 GERMANY
                    9.3.1.1 Government initiatives and well-established standards to drive market
                                TABLE 48 GERMANY: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 49 GERMANY: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
                                TABLE 50 GERMANY: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           9.3.2 UK
                    9.3.2.1 Increasing hospital admissions to drive market
                                TABLE 51 UK: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 52 UK: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
                                TABLE 53 UK: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           9.3.3 FRANCE
                    9.3.3.1 Growing diagnostic medical device market with rising chronic diseases to propel market
                                TABLE 54 FRANCE: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 55 FRANCE: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
                                TABLE 56 FRANCE: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           9.3.4 ITALY
                    9.3.4.1 Increasing use of diagnostic devices and government initiatives to drive market
                                TABLE 57 ITALY: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 58 ITALY: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
                                TABLE 59 ITALY: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           9.3.5 SPAIN
                    9.3.5.1 Increasing focus on reducing hospital costs to drive market
                                TABLE 60 SPAIN: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 61 SPAIN: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
                                TABLE 62 SPAIN: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           9.3.6 REST OF EUROPE
                    TABLE 63 REST OF EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 64 REST OF EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
                    TABLE 65 REST OF EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    9.4 ASIA PACIFIC
          FIGURE 32 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET SNAPSHOT
          TABLE 66 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 67 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 68 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
          TABLE 69 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           9.4.1 AUSTRALIA
                    9.4.1.1 Growing adoption of medical devices for diagnosis and treatment to drive market
                                TABLE 70 AUSTRALIA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 71 AUSTRALIA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
                                TABLE 72 AUSTRALIA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           9.4.2 JAPAN
                    9.4.2.1 Regulatory reforms and need to reduce hospital costs to drive market
                                TABLE 73 JAPAN: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 74 JAPAN: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
                                TABLE 75 JAPAN: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           9.4.3 CHINA
                    9.4.3.1 Government initiatives and developing economy to drive market
                                TABLE 76 CHINA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 77 CHINA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
                                TABLE 78 CHINA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           9.4.4 INDIA
                    9.4.4.1 Government initiatives for diagnosis and treatment to drive market
                                TABLE 79 INDIA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 80 INDIA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE 2020–2027 (USD MILLION)
                                TABLE 81 INDIA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           9.4.5 REST OF ASIA PACIFIC
                    TABLE 82 REST OF ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 83 REST OF ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
                    TABLE 84 REST OF ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    9.5 LATIN AMERICA
           9.5.1 INCREASING CHRONIC DISEASES AND ADOPTION OF MEDICAL DEVICES TO DRIVE MARKET
                    TABLE 85 LATIN AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 86 LATIN AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
                    TABLE 87 LATIN AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    9.6 MIDDLE EAST & AFRICA
           9.6.1 EMERGENCE OF REGULATORY FRAMEWORKS TO DRIVE MARKET
                    TABLE 88 MIDDLE EAST & AFRICA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 89 MIDDLE EAST & AFRICA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
                    TABLE 90 MIDDLE EAST & AFRICA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 126)
     10.1 OVERVIEW
     10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
             10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MEDICAL DEVICE REPROCESSING MARKET
     10.3 REVENUE SHARE ANALYSIS OF KEY PLAYERS
             FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN MEDICAL DEVICE REPROCESSING MARKET
     10.4 MARKET SHARE ANALYSIS, 2021
             FIGURE 34 MEDICAL DEVICE REPROCESSING MARKET SHARES, BY KEY PLAYER, 2021
             TABLE 91 MEDICAL DEVICE REPROCESSING MARKET: DEGREE OF COMPETITION
     10.5 COMPETITIVE BENCHMARKING
             TABLE 92 MEDICAL DEVICE REPROCESSING MARKET: DETAILED LIST OF SMALL AND MEDIUM PLAYERS
     10.6 COMPANY FOOTPRINT
             TABLE 93 FOOTPRINT OF COMPANIES IN MEDICAL DEVICE REPROCESSING MARKET
             TABLE 94 SERVICE FOOTPRINT OF COMPANIES (16 COMPANIES)
             TABLE 95 APPLICATION FOOTPRINT OF COMPANIES (16 COMPANIES)
             TABLE 96 REGIONAL FOOTPRINT OF COMPANIES (16 COMPANIES)
     10.7 COMPANY EVALUATION QUADRANT
             10.7.1 STARS
             10.7.2 EMERGING LEADERS
             10.7.3 PERVASIVE PLAYERS
             10.7.4 PARTICIPANTS
                        FIGURE 35 MEDICAL DEVICE REPROCESSING MARKET: COMPANY EVALUATION QUADRANT (2021)
     10.8 COMPETITIVE SCENARIO
             10.8.1 FDA APPROVALS/SERVICE ENHANCEMENTS
             10.8.2 DEALS
             10.8.3 OTHER DEVELOPMENTS

11 COMPANY PROFILES (Page No. - 140)
     11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             11.1.1 STRYKER CORPORATION
                        TABLE 100 STRYKER CORPORATION: COMPANY OVERVIEW
                        FIGURE 36 STRYKER CORPORATION: COMPANY SNAPSHOT (2021)
             11.1.2 JOHNSON & JOHNSON
                        TABLE 101 JOHNSON & JOHNSON: COMPANY OVERVIEW
                        FIGURE 37 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2021)
             11.1.3 MEDTRONIC PLC
                        TABLE 102 MEDTRONIC PLC: COMPANY OVERVIEW
                        FIGURE 38 MEDTRONIC PLC: COMPANY SNAPSHOT (2021)
             11.1.4 STERIS HEALTHCARE
                        TABLE 103 STERIS HEALTHCARE: COMPANY OVERVIEW
                        FIGURE 39 STERIS HEALTHCARE: COMPANY SNAPSHOT (2021)
             11.1.5 CARDINAL HEALTH (SUSTAINABLE TECHNOLOGIES)
                        TABLE 104 CARDINAL HEALTH: COMPANY OVERVIEW
                        FIGURE 40 CARDINAL HEALTH: COMPANY SNAPSHOT (2021)
             11.1.6 ARJO GROUP (RENU MEDICAL, INC.)
                        TABLE 105 ARJO GROUP: COMPANY OVERVIEW
                        FIGURE 41 ARJO GROUP: COMPANY SNAPSHOT (2021)
             11.1.7 VANGUARD AG
                        TABLE 106 VANGUARD AG: COMPANY OVERVIEW
             11.1.8 MEDLINE RENEWAL
                        TABLE 107 MEDLINE RENEWAL: COMPANY OVERVIEW
             11.1.9 INNOVATIVE HEALTH
                        TABLE 108 INNOVATIVE HEALTH: COMPANY OVERVIEW
             11.1.10 STERIPRO CANADA, INC
                        TABLE 109 STERIPRO CANADA, INC.: COMPANY OVERVIEW
             11.1.11 NORTHEAST SCIENTIFIC, INC.
                        TABLE 110 NE SCIENTIFIC, INC.: COMPANY OVERVIEW
     11.2 OTHER PLAYERS
             11.2.1 SURETEK MEDICAL
             11.2.2 KONOIKE GROUP
             11.2.3 AVANTE HEALTH SOLUTIONS
             11.2.4 MEDSALV
             11.2.5 VITRUVIA MEDICAL AG

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX (Page No. - 169)
     12.1 INSIGHTS FROM INDUSTRY EXPERTS
     12.2 DISCUSSION GUIDE
     12.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     12.4 CUSTOMIZATION OPTIONS
     12.5 RELATED REPORTS
     12.6 AUTHOR DETAILS